SS-31 (Elamipretide)
Mitochondria-targeted tetrapeptide. Phase II in heart failure and Barth syndrome. Cardiolipin binding.
Index entry
Research context
Mitochondria-targeted tetrapeptide. Phase II in heart failure and Barth syndrome. Cardiolipin binding.
How to read this entry
The current evidence grade is Phase I / II. It describes the strongest verified research stage represented in the record; it is not a statement of safety, efficacy or suitability for use.
Editorial scope
This entry is an evidence index, not medical guidance. Detailed mechanisms, open questions and primary references can be added through the structured editorial importer as the record is reviewed.